Skip to main content

New Products

  • FDA approves sensor, mobile app designed to better control asthma, COPD

    MADISON, Wis. — Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, earlier this week announced that the Food and Drug Administration granted 510(k) clearance to market its latest generation of the Propeller platform, including a new sensor.

  • FDA approves Zontivity tabs

    SILVER SPRING, Md. — The Food and Drug Administration on Thursday approved Zontivity (vorapaxar) tablets, an anti-platelet agent that's designed to decrease the tendency of platelets to clump together to form a blood clot. Zontivity is the first in a new class of drugs called a protease-activated receptor-1 (PAR-1) antagonist, the agency said.

  • Telehealth provider Teladoc to accelerate growth with AmeriDoc acquisition

    DALLAS — Teladoc, a telehealth provider with more than 7.5 million members, has announced the acquisition of AmeriDoc, a telehealth company founded in 2007.

    Teladoc stated that the acquisition supports its strategy for growth into new and fast-growing market segments.

  • Wegmans makes Lifeclinic 500 health stations available to patients for better health tracking

    ROCHESTER, N.Y. — Wegmans Food Markets is making it easy for patients to monitor their blood pressure with a stop to the pharmacy at any store, the company announced Wednesday. That’s where customers can find a health station that lets them take their own vital statistics and track them over time, providing the kind of record doctors often ask patients to keep. The Lifeclinic 500 stations can measure blood pressure, pulse, weight and calculate body mass index.

  • Actavis launches generic Catapres-TTS

    DUBLIN — Actavis announced that it has launched a generic version of Boehringer Ingelheim's Catapres-TTS (clonidine transdermal system, USP, 0.1-mg/day, 0.2-mg/day, and 0.3-mg/day for one week), following the company's final approval on its abbreviated new drug application from the Food and Drug Administration.

    Catapres-TTS is used for the treatment of hypertension. The drug had total U.S. sales of approximately $180 million for the 12 months ending Feb. 28, 2014, according to IMS Health.

     

  • Breyers goes gluten-free

    ENGLEWOOD CLIFFS, N.J. — Breyers announced that it will begin offering 36 gluten-free varieties, which will feature a "gluten-free" claim, in line with the Food and Drug Administration's rule on gluten-free labeling.

  • IHS Technology report: Sales of home health tech expected to double over next five years

    EL SEGUNDO, Calif. — Medical providers’ efforts to reduce costs by taking a more holistic approach to healthcare will spur a doubling in the global market for home health technologies in the coming years, according to an IHS Technology report released Thursday titled “World Market for Home Health Technologies – 2014.”

  • Dove launches first premium skin care line

    ENGLEWOOD CLIFFS, N.J. — Global beauty brand Dove announced the launch of Dove DermaSeries, a range of cleansers and creams that can be used to care for extremely dry skin. DermaSeries marks the brand's first premium skin care line.

    Dove partnered with dermatologists for the line to provide critical insight into the science behind dry skin, including Dr. Ranella Hirsch, a fellow of the American Academy of Dermatology.

X
This ad will auto-close in 10 seconds